Add time:08/17/2019         Source:sciencedirect.com

Recently, a novel series of amidines has been described, exhibiting high NR2B-subtype selective N-methyl-D-aspartate (NMDA) antagonist activity with nanomolar or subnanomolar affinity. Within the styrylamidine subclass, (E)-N-(2-methoxybenzyl)-3-phenyl-acrylamidine (1), displayed the highest affinity (Ki=0.7 nM versus [3H]ifenprodil) and was considered an appropriate candidate for isotopic labelling with carbon-11 (T1/2: 20.38 min) at its methoxy group for imaging of NMDA receptors with PET. Derivative 1 has been labelled from the corresponding nor-analogue using [11C]methyl triflate and the following experimental conditions : (1) trapping at −10 °C of [11C]methyl triflate in 300 μL of acetone containing 0.6–0.8 mg of precursor 5 (2.4–3.2 μmol) and 5 μL of a 3 M solution of NaOH in water (about 5 eq.); (2) concentration to dryness of the reaction mixture (at 110 °C, using a helium stream for 1–2 min); (3) taking up the residue with 0.5 mL of the HPLC mobile phase and (4) purification using semi-preparative HPLC (SymmetryPrep® C-18, Waters, 300×7.8 mm). Typically, starting from a 1.5 Ci (55.5 GBq) [11C]CO2 production batch, 120–240 m Ci (4.44–8.88 GBq) of [11C]-1 (20–40% decay-corrected radiochemical yield, n=5) was obtained within a total synthesis time of 25–30 min. Specific radioactivities ranged from 0.8 to 1.2 Ci/μmol (29.6–44.4 GBq/μmol) at the end of radiosynthesis. No attempts were made to further optimise these reactions, as sufficient material was obtained to allow for preliminary pharmacological characterisation.

We also recommend Trading Suppliers and Manufacturers of Acrylamidine (cas 19408-49-2). Pls Click Website Link as below: cas 19408-49-2 suppliers